 |
市場調査レポート
商品コード
1458117
神経刺激装置の世界市場規模、シェア、成長分析：タイプ別、用途別 - 産業予測（2024年～2031年）Global Neurostimulation Devices Market Size, Share, Growth Analysis, By Type(Implantable Devices and Non-Implantable Devices), By Application(Pain Management and Parkinson's Disease) - Industry Forecast 2024-2031 |
||||||
| 神経刺激装置の世界市場規模、シェア、成長分析：タイプ別、用途別 - 産業予測（2024年～2031年） |
|
出版日: 2024年03月27日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の神経刺激装置の市場規模は、2022年に53億米ドルとなり、2023年の59億8,000万米ドルから2031年には156億7,000万米ドルに拡大し、予測期間中（2024年～2031年）にCAGR12.80%で成長すると予測されています。
神経刺激装置市場は、さまざまな要因によって力強い成長を遂げています。高齢者人口、先進製品の導入、アドオン療法需要の増加、片頭痛やてんかんのような慢性疾患の増加などです。さらに、これらの疾患分野におけるアンメット・メディカル・ニーズの高さ、神経疾患や生活習慣病の蔓延も市場拡大に寄与しています。低侵襲手術の需要とともに、研究開発のための外部資金がこの成長をさらに後押ししています。米国神経学会によると、脳卒中とアルツハイマー病は米国における主要な死因の一つであり、パーキンソン病は毎年かなりの数の米国人が罹患しています。神経疾患の罹患率の上昇に伴い、神経刺激装置の需要は拡大すると予測されています。新興国市場は研究開発に多額の投資を行い、植え込み型神経刺激装置のような先進的な製品に注力しています。さらに、神経刺激装置の植え込みは侵襲性が低いため、入院期間の短縮や回復時間の短縮につながり、市場に新たな成長の道を開くと見られています。
目次
エグゼクティブサマリー
- 市場概要
- 転変
調査手法
- 情報調達
- 二次・一次情報源
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
神経刺激装置の世界市場：タイプ別
- 市場概要
- 植込み型デバイスと非植込み型デバイス
神経刺激装置の世界市場：用途別
- 市場概要
- 疼痛管理とパーキンソン病
神経刺激装置の世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
- ラテンアメリカ
- ブラジル
- その他ラテンアメリカ
- 中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主要市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Medtronic（Ireland）
- Abbott Laboratories（US）
- Boston Scientific Corporation（US）
- LivaNova PLC（U.K.）
- Nevro Corp.（US）
- NeuroPace, Inc.（US）
- Synapse Biomedical Inc.（US）
- Neuronetics, Inc.（US）
- Cyberonics, Inc.（US）
- St. Jude Medical, Inc.（US）
- Cogentix Medical, Inc.（US）
- NDI Medical LLC（US）
- Stimwave Technologies（US）
- BioControl Medical（Israel）
- EndoStim（US）
- EnteroMedics（US）
- Aleva Neurotherapeutics（Switzerland）
- SPR Therapeutics（US）
- electroCore, Inc.（US）
- Soterix Medical Inc.（US）
Global Neurostimulation Devices Market size was valued at USD 5.3 Billion in 2022 and is poised to grow from USD 5.98 Billion in 2023 to USD 15.67 Billion by 2031, at a CAGR of 12.80% during the forecast period (2024-2031).
The neurostimulation device market is experiencing robust growth driven by various factors. These include an aging population, the introduction of advanced products, increasing demand for add-on therapy, and a rise in chronic diseases like migraine and epilepsy. Additionally, high unmet medical needs in these disease segments, coupled with the prevalence of neurological disorders and lifestyle-related diseases, contribute to market expansion. External funding for research and development, along with the demand for minimally invasive surgeries, further fuel this growth. According to the American Academy of Neurology, stroke and Alzheimer's rank among the leading causes of death in the United States, while Parkinson's disease affects a significant number of Americans annually. With the rising incidence of neurological diseases, the demand for neurostimulation devices is projected to escalate. Manufacturers are heavily investing in research and development, focusing on advanced products like implantable neurostimulation devices, which are anticipated to propel market growth. Moreover, the less invasive nature of neurostimulation device implantation, leading to shorter hospital stays and quicker recovery times, is poised to open up new growth avenues for the market.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neurostimulation Devices Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Neurostimulation Devices Market Segmental Analysis
Global Neurostimulation Devices market is segmented by type, Application, and region. Based on type, the market can be segmented into implantable devices and non-implantable devices. Based on Application, the market is segmented into pain management, and Parkinson's disease. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Neurostimulation Devices Market
The escalating occurrence of neurological disorders globally serves as a primary catalyst for the growth of the neurostimulation devices market. With neurological disorders, including Parkinson's disease, epilepsy, and chronic pain, imposing a substantial burden of disease worldwide, millions of individuals are affected, as highlighted by the World Health Organization. This burgeoning prevalence underscores the escalating demand for neurostimulation devices as a viable treatment solution. Consequently, manufacturers are channeling investments into research and development endeavors aimed at innovating advanced neurostimulation devices, thus contributing to the anticipated expansion of the market.
Restraints in the Global Neurostimulation Devices Market
Despite the increasing need for neurostimulation devices, their steep prices continue to pose a significant obstacle to market expansion. The high cost places a considerable financial strain on patients, particularly those residing in low- and middle-income nations. Moreover, the scarcity of proficient healthcare practitioners and the restricted accessibility of these devices in certain areas further stifle market progression. Additionally, the potential hazards linked with device implantation, including infection and malfunction, could also hinder market advancement.
Market Trends of the Global Neurostimulation Devices Market
A prominent trend in the neurostimulation devices market is the advancement of minimally invasive and non-invasive technologies, which are increasingly favored for their benefits over conventional surgical methods such as decreased pain, shorter hospital stays, and quicker recovery. Furthermore, the emergence of wireless and implantable devices is contributing to market expansion by providing patients with enhanced comfort and convenience without the need for external wires or bulky devices. This shift towards less invasive neurostimulation technologies is projected to persist, driving further market growth in the foreseeable future.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Neurostimulation Devices Market by Type
- Market Overview
- Implantable Devices and Non-Implantable Devices
Global Neurostimulation Devices Market by Application
- Market Overview
- Pain Management and Parkinson's Disease
Global Neurostimulation Devices Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LivaNova PLC (U.K.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nevro Corp. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NeuroPace, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Synapse Biomedical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Neuronetics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cyberonics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- St. Jude Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cogentix Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NDI Medical LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stimwave Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioControl Medical (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- EndoStim (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- EnteroMedics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Aleva Neurotherapeutics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- SPR Therapeutics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- electroCore, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Soterix Medical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
